Cassella James V has filed 4 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 215000 shares of Trevi Therapeutics, Inc. ($TRVI) on February 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Trevi Therapeutics, Inc. | $TRVI | Cassella James V | Chief Development Officer | A | Stock Option (right to buy) | 215000 | $0.00 | 215,000.0000 | 145,104,986 | 9999.99% | 0.15% |
| Feb. 18, 2025 | Trevi Therapeutics, Inc. | $TRVI | Cassella James V | Chief Development Officer | A | Stock Option (right to buy) | 257500 | $0.00 | 257,500.0000 | 101,971,873 | 9999.99% | 0.25% |
| Sept. 30, 2024 | Trevi Therapeutics, Inc. | $TRVI | Cassella James V | Chief Development Officer | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 99,033,373 | 9999.99% | 0.40% |
| June 13, 2024 | Trevi Therapeutics, Inc. | $TRVI | Cassella James V | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |